Phase II trial of biochemotherapy with interferon α, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: A Southwest Oncology Group trial

  • Kim A. Margolin
  • , P. Y. Liu
  • , Joseph M. Unger
  • , William S. Fletcher
  • , Lawrence E. Flaherty
  • , Walter J. Urba
  • , Evan M. Hersh
  • , Laura E. Hutchins
  • , Jeffrey A. Sosman
  • , John W. Smith
  • , Geoffrey R. Weiss
  • , Vernon K. Sondak

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of biochemotherapy with interferon α, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: A Southwest Oncology Group trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences